Important notice

Warning – Fraudulent Calls

Several persons have received fraudulent calls impersonating RAMQ. If you do not have a pending request with us or if the call seems suspicious, do not provide any personal information. Make a note of the agent’s name, end the conversation and call us. To find out more, refer to Our communication practices webpage.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

58 results found.

Example of search result explained

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114162
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114161

Hulio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114163

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114041
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114042

Hulio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114043

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114104
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114105

Hulio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114106

Yuflyma (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,2 mL) DIN : 99114508
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114504
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114505

Yuflyma (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114506
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114507
Page 6 of 6

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.